MedPath

Reducing Dialysate Sodium Effect on Blood Pressure Variability in Hemodialysis Patients

Not Applicable
Conditions
Hemodialysis Patients
Interventions
Procedure: standard hemodialysis
Procedure: lower dialysate sodium dialysis
Registration Number
NCT05169125
Lead Sponsor
Mansoura University
Brief Summary

In this study the investigators aim to test the effect of lowering dialysate sodium concentration on visit-to-visit blood pressure variability in hemodialysis patients who have achieved their dry weight.

Detailed Description

Cardiovascular diseases are considered the major cause of mortality in maintenance hemodialysis patients. Nevertheless, hypertension is recognized as an important modifiable risk factor for cardiovascular disease among hemodialysis (HD) patients.

Apart from blood pressure levels, BP variability, which reflects the fluctuation in BP, has been described as an independent risk factor that linearly associated with all-cause and cardiovascular mortality in HD patients.

BPV is categorized as either long or short term, based on the time interval over which it is considered. In the dialysis population, long-term BPV is typically defined on the basis of BP measurements taken at the start of each thrice-weekly hemodialysis treatment (interdialytic BPV). On the other hand, short-term BPV among dialysis patients can be considered in terms of variability that occurs during hemodialysis treatments (intradialytic BPV). Researchers believed that the mitigation strategies of BPV must be paid attention to.

Sodium load is associated with thirst, fluid retention, interdialysis weight gain and hypertension for hemodialysis patients, therefore the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guideline highlighted the importance of limiting sodium intake and adequate sodium removal which is considered one of the most important goals of the dialysis therapy.

Interestingly, a recent study showed that mild decrease in dialysate sodium concentration could improve systolic blood pressure variability in HD patients at their dry weight, thus improving blood pressure complications and subsequent complications. However, whether improving sodium balance could potentially contribute to better BPV management in HD patients has not been assessed in a randomized manner. Therefore, this study aims to investigate whether lowering dialysate sodium concentration could help mitigate long term (interdialytic) BPV in hemodialysis patients in a randomized controlled manner.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Patients' age ≥18 years
  • Patients who had been on regular hemodialysis for at least 3 months.
  • Patients' residual daily urine output is less than 100 mL/day.
  • Pre study one week average systolic BP ≥120 mmHg but ≤ 180 mmHg.
  • Patients who have achieved their dry weight as assessed by clinical examination.
  • Predialytic serum sodium level ≥ 140mmol/l.
  • Kt/V ≥ 1.2
Read More
Exclusion Criteria
  • Patients who have advanced heart failure or permanent atrial fibrillation decompensated liver disease, neoplastic illness, overt edema.
  • History of acute cardiovascular accidents or infections during 3 months preceding entry into the study.
  • Patients prone to hypotension or other intradialytic adverse events.
  • Patients participating in another interventional study that may affect blood pressure.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group A: standard hemodialysis.standard hemodialysispatients who will undergo standard hemodialysis (dialysate sodium concentration 143 mmoL/L)
Group B: lower dialysate sodium hemodialysis.lower dialysate sodium dialysispatients who will undergo hemodialysis with lower dialysate sodium concentration (140 mmoL/L).
Primary Outcome Measures
NameTimeMethod
blood pressure variability.2 weeks after the study duration (3 months).

visit to visit blood pressure variability in both groups.

Secondary Outcome Measures
NameTimeMethod
the frequency of intradialytic adverse events2 weeks after the study duration (3 months).

the frequency of intradialytic adverse events as hypotensive crises and cramps.

interdialytic weight gain2 weeks after the study duration (3 months).

interdialytic weight gain

antihypertensive medication regimen2 weeks after the study duration (3 months).

antihypertensive medication regimen

© Copyright 2025. All Rights Reserved by MedPath